Literature DB >> 6651485

Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results.

S Slopek, I Durlakowa, B Weber-Dabrowska, A Kucharewicz-Krukowska, M Dabrowski, R Bisikiewicz.   

Abstract

The results of treatment with specific bacteriophages of 184 nosologic units diagnosed in 138 cases as septic bacterial infections, presented in the first part of this report, were submitted to detailed analysis. The results obtained revealed that phage therapy may be successfully applied in the treatment of septic infections induced by Staphylococcus, Klebsiella, Escherichia, Proteus and Pseudomonas as well as of the digestive system infections induced by Shigella and Salmonella. They also widened the scope of phage therapy application.

Entities:  

Mesh:

Year:  1983        PMID: 6651485

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  13 in total

Review 1.  Bacteriophage therapy.

Authors:  A Sulakvelidze; Z Alavidze; J G Morris
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Phage treatment of human infections.

Authors:  Stephen T Abedon; Sarah J Kuhl; Bob G Blasdel; Elizabeth Martin Kutter
Journal:  Bacteriophage       Date:  2011-03

Review 3.  Therapeutics and delivery vehicles for local treatment of osteomyelitis.

Authors:  Leah H Cobb; Emily M McCabe; Lauren B Priddy
Journal:  J Orthop Res       Date:  2020-04-21       Impact factor: 3.494

4.  Isolation and characterisation of KP34--a novel φKMV-like bacteriophage for Klebsiella pneumoniae.

Authors:  Zuzanna Drulis-Kawa; Paweł Mackiewicz; Agata Kęsik-Szeloch; Ewa Maciaszczyk-Dziubinska; Beata Weber-Dąbrowska; Agata Dorotkiewicz-Jach; Daria Augustyniak; Grażyna Majkowska-Skrobek; Tomasz Bocer; Joanna Empel; Andrew M Kropinski
Journal:  Appl Microbiol Biotechnol       Date:  2011-02-16       Impact factor: 4.813

Review 5.  Phage therapy of pulmonary infections.

Authors:  Stephen T Abedon
Journal:  Bacteriophage       Date:  2015-04-18

6.  Prospects for Biocontrol of Vibrio parahaemolyticus Contamination in Blue Mussels (Mytilus edulus)-A Year-Long Study.

Authors:  Bukola A Onarinde; Ronald A Dixon
Journal:  Front Microbiol       Date:  2018-06-05       Impact factor: 5.640

Review 7.  Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review.

Authors:  Krystyna Dąbrowska
Journal:  Med Res Rev       Date:  2019-03-19       Impact factor: 12.944

8.  Bacteriophage: time to re-evaluate the potential of phage therapy as a promising agent to control multidrug-resistant bacteria.

Authors:  Masoud Sabouri Ghannad; Avid Mohammadi
Journal:  Iran J Basic Med Sci       Date:  2012-03       Impact factor: 2.699

Review 9.  Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.

Authors:  Zuzanna Drulis-Kawa; Grazyna Majkowska-Skrobek; Barbara Maciejewska; Anne-Sophie Delattre; Rob Lavigne
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

Review 10.  [Phage therapy, an alternative to antibiotic therapy?)].

Authors:  J Reina; N Reina
Journal:  Rev Esp Quimioter       Date:  2018-02-16       Impact factor: 1.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.